Clinical Trials Directory

Trials / Unknown

UnknownNCT02706509

Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women

Comparison Between the Analgesic Affects of Tramadol® and "Verbal Anesthesia" on Pain Management Associated With the Insertion of Jaydess® in Nulliparous Women

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
Female
Age
18 Years – 48 Years
Healthy volunteers
Accepted

Summary

A multicenter prospective interventional comparative study that investigate pain management during Jaydess insertion in nulliparous women that will be tested by the analgesic affects of oral tramadol or 'verbal anesthesia' on the patients.

Detailed description

Most intrauterine contraception (IUC) insertions do not require pain management. However, small proportions of nulliparous women experience substantial pain that needs to be proactively managed No prophylactic pharmacological intervention has been adequately evaluated to support routine use for pain reduction during or after IUC insertion. Women's anxiety about the procedure may contribute to higher levels of perceived pain, which highlights the importance of counselling, and creating a trustworthy, unhurried and professional atmosphere in which the experience of the provider also has a major role; a situation frequently referred to as 'verbal anaesthesia'. It has been proven in the past that the use of oral Tramadol can reduce the pain in the insertion. In the study investigators will compare the analgesic affects of oral Tramadol and verbal anesthesia on pain relief during Jaydess insertion in nulliparous women.

Conditions

Interventions

TypeNameDescription
DRUGTramadolpatient will receive oral Tramadol 50 mg an hour before IUD insertion
BEHAVIORALVerbal anesthesiapatient will receive full explanation about the procedure for five minutes before IUD insertion
DEVICEJaydessPatient will go through an insertion of Jaydess intrauterine device.

Timeline

Start date
2016-03-01
Primary completion
2017-09-01
Completion
2018-12-01
First posted
2016-03-11
Last updated
2016-03-11

Source: ClinicalTrials.gov record NCT02706509. Inclusion in this directory is not an endorsement.